Costanzo, G., Curatolo, S., Bus, B., Belfiore, A
## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review
The mechanisms of GSH activity are both direct and indirect, the latter by maintaining other cellular antioxidants in a functional state
GLP-1 Works Best With Simple Habits You do not need extreme diets or intense workouts to benefit from GLP-1 medications
Bergmann NC, Gasbjerg LS, Heimbrger SM, Krogh LSL, Dela F, Hartmann B, et al
Ships in temperature-controlled packaging via priority courier